Raphael Pharmaceutical RAPH
OTC RAPH
$1.51 +0.00 (+0.00%)
At close: Nov 6, 2026 · 4:00 PM EST

Raphael Pharmaceutical (RAPH) Change in Other Operating Liabilities (2024 - 2025)

Updated

Analysis

Raphael Pharmaceutical (RAPH) Change in Other Operating Liabilities (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 2.69 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -34.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -113.00 Mn
10 Raphael Pharmaceutical 30.47 Mn 30.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 291,000.00
Sep 30, 2025 191,000.00
Dec 31, 2024 -405,000.00
API Access

Raphael Pharmaceutical Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=RAPH&period=max&api_key=YOUR_API_KEY